New task order award alcohol CUE human laboratory study testing apremilast. Contractor to serve as a clinical research site for a multiple-site clinical trial to test apremilast for the treatment of…
Active Awarded Last action
- Contract number
- 75N94025F00002
- Awardee
-
University Of California, LOS Angeles UEI RN64EPNH8JC6
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $579,102
Award facts
- Opportunity
-
- NIAAACSHLAB004 Solicitation number
- Contract value 100% obligated
- $579,102.00 Current and potential, with all options
- Completion date 94% complete
- Current and potential, with all options
- Funding agency
- National Institute on Alcohol Abuse and Alcoholism National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Los Angeles, CA 90095, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a delivery order valued at $579,102 to the University of California, Los Angeles (UCLA) on September 18, 2025, for a clinical research site task order supporting a multi-site clinical trial investigating apremilast as a treatment for alcohol use disorder. This award is issued under the Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network, a master indefinite delivery/indefinite quantity (IDIQ) contract vehicle designed to establish a distributed network of clinical research sites capable of conducting coordinated pharmaceutical trials. UCLA's Office of Research Administration will conduct the alcohol cue human laboratory study at the Los Angeles location, with performance extending through November 17, 2026. The contract carries no set-aside designation and operates under a cost-no-fee pricing structure.
This task order positions UCLA as a clinical research partner within NIAAA's broader medications development program, which seeks to identify and test pharmacological interventions for alcohol use disorder treatment. As a research-intensive institution with extensive clinical trial infrastructure and biomedical expertise, UCLA is well-suited to execute the rigorous laboratory protocols and patient engagement requirements inherent in alcohol cue reactivity studies. The delivery order mechanism provides NIAAA flexibility to scale research capacity across multiple sites while maintaining consistent methodological standards across the clinical investigations network.
Description
New task order award alcohol CUE human laboratory study testing apremilast. Contractor to serve as a clinical research site for a multiple-site clinical trial to test apremilast for the treatment of alcohol use disorder.
Quick answers
Who was awarded contract 75N94025F00002?
75N94025F00002 was awarded to University Of California, LOS Angeles by National Institute of Child Health and Human Development (National Institutes of Health) on September 18, 2025.
How much is contract 75N94025F00002 worth?
The government has obligated $579,102 on 75N94025F00002.
Which agency awarded contract 75N94025F00002?
National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94025F00002, with funding from National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health).
Is contract 75N94025F00002 an order under another contract?
Yes. 75N94025F00002 is a delivery order under 75N94021D00008, an indefinite delivery contract, on Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder.
Was contract 75N94025F00002 competed?
The extent of competition for 75N94025F00002 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award